Cp. Vicente et al., Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding, THROMB HAEM, 86(5), 2001, pp. 1215-1220
We compared the anticoagulant, antithrombotic and bleeding effects of highl
y sulfated dermatan sulfates from invertebrates and their mammalian counter
part. An invertebrate dermatan sulfate containing 2-O-sulfated alpha -L-idu
ronic acid and 4-O-sulfated N-acetyl-beta -D-galactosamine residues is a po
tent anticoagulant due to a high heparin cofactor II activity. It inhibits
thrombin due to the formation of a covalent complex with heparin cofactor I
I, as in the case of mammalian dermatan sulfate, but the effect occurs at l
ower concentrations for the invertebrate polysaccharide, Surprisingly, the
invertebrate dermatan sulfate has a lower potency to prevent thrombus forma
tion on an experimental model and a lower bleeding, effect in rats than the
mammalian dermatan sulfate. In contrast, another invertebrate dermatan sul
fate, also enriched in 2-O-sulfated alpha -L-iduronic acid, but in this cas
e sulfated at O-6 position of the N-acetyl-beta -D-galactosamine units, has
no in vitro or in vivo anticoagulant activity, does not prevent thrombus f
ormation but shows a bleeding effect similar to the mammalian glycosaminogl
ycan. Overall, these results demonstrate unbalanced effects of dermatan sul
fates with different sulfation patterns on coagulation, thrombosis and blee
ding, and raise interesting questions concerning the relationship among the
se three biological actions of sulfated polysaccharides.